rabeprazole has been researched along with Starvation in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Starvation: Lengthy and continuous deprivation of food. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katagiri, F | 1 |
| Inoue, S | 1 |
| Sato, Y | 1 |
| Itoh, H | 1 |
| Takeyama, M | 1 |
1 trial available for rabeprazole and Starvation
| Article | Year |
|---|---|
Comparison of the effects of proton pump inhibitors on human plasma adrenocorticotropic hormone and cortisol levels under the starved condition.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adrenocorticotropic Hormone; Adult; A | 2006 |